Ito D - Search Results

1

Improvement in health-related quality of life with recombinant factor IX prophylaxis in severe or moderately severe haemophilia B patients: results from the BAX326 Pivotal Study.

Windyga J, Lin VW, Epstein JD, Ito D, Xiong Y, Abbuehl BE, Ramirez JH. Windyga J, et al. Among authors: ito d. Haemophilia. 2014 May;20(3):362-8. doi: 10.1111/hae.12315. Epub 2013 Nov 20. Haemophilia. 2014. PMID: 24251442 Clinical Trial.

2

Oladapo AO, Epstein JD, Williams E, Ito D, Gringeri A, Valentino LA. Oladapo AO, et al. Among authors: ito d. Haemophilia. 2015 Sep;21(5):e344-58. doi: 10.1111/hae.12759. Epub 2015 Jul 17. Haemophilia. 2015. PMID: 26390060 Review.

3

Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy.

Wasserman RL, Ito D, Xiong Y, Ye X, Bonnet P, Li-McLeod J. Wasserman RL, et al. Among authors: ito d. J Clin Immunol. 2017 Feb;37(2):180-186. doi: 10.1007/s10875-017-0371-0. Epub 2017 Feb 3. J Clin Immunol. 2017. PMID: 28160239 Free PMC article.

4

Impact of an active hemostatic product treatment approach on bleeding-related complications and hospital costs among inpatient surgeries in the United States.

Iannitti DA, Kim C, Ito D, Epstein J. Iannitti DA, et al. Among authors: ito d. J Med Econ. 2021 Jan-Dec;24(1):514-523. doi: 10.1080/13696998.2021.1916751. J Med Econ. 2021. PMID: 33858281 Free article.

5

The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature.

Abdelal R, Banerjee AR, Carlberg-Racich S, Darwaza N, Ito D, Epstein J. Abdelal R, et al. Among authors: ito d. Subst Abus. 2022;43(1):774-784. doi: 10.1080/08897077.2021.2010252. Subst Abus. 2022. PMID: 35112993 Free article. Review.

6

Health Care Resource Utilization and Total Costs of Care for Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims Analysis.

Ito D, Feng C, Fu C, Kim C, Wu J, Dalton D, Epstein J, Snider JT, DuVall AS. Ito D, et al. Clin Ther. 2024 Jan;46(1):3-11. doi: 10.1016/j.clinthera.2023.10.020. Epub 2023 Nov 18. Clin Ther. 2024. PMID: 37981560 Free article.

7

Routes J, Costa-Carvalho BT, Grimbacher B, Paris K, Ochs HD, Filipovich A, Hintermeyer M, de Melo KM, Workman S, Ito D, Ye X, Bonnet P, Li-McLeod J. Routes J, et al. Among authors: ito d. J Clin Immunol. 2016 Jul;36(5):450-61. doi: 10.1007/s10875-016-0279-0. Epub 2016 Apr 18. J Clin Immunol. 2016. PMID: 27091140 Free PMC article.

8

Real-world study of multiple naloxone administrations for opioid overdose reversal among emergency medical service providers.

Abdelal R, Banerjee AR, Carlberg-Racich S, Cebollero C, Darwaza N, Kim C, Ito D, Epstein J. Abdelal R, et al. Among authors: ito d. Subst Abus. 2022;43(1):1075-1084. doi: 10.1080/08897077.2022.2060433. Subst Abus. 2022. PMID: 35442869 Free article.

9

Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.

Abdelal R, Raja Banerjee A, Carlberg-Racich S, Darwaza N, Ito D, Shoaff J, Epstein J. Abdelal R, et al. Among authors: ito d. Harm Reduct J. 2022 May 20;19(1):49. doi: 10.1186/s12954-022-00627-3. Harm Reduct J. 2022. PMID: 35596213 Free PMC article.

10

Health resource utilization and costs of care for adult patients with relapsed or refractory mantle cell lymphoma in the United States: a retrospective claims analysis.

Ito D, Feng C, Fu C, Kim C, Wu J, Epstein J, Snider JT, DuVall AS. Ito D, et al. Expert Rev Pharmacoecon Outcomes Res. 2023 Jul-Dec;23(7):773-787. doi: 10.1080/14737167.2023.2216458. Epub 2023 Jun 6. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 37278284

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

682 results

Search Page